• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Atsufumi Kawabata, Ryotaro Kuroda, +6 authors Kenzo Kawai
  • Biology, Medicine
  • Life sciences
  • 2002 (First Publication: 1 October 2002)
  • Protease-activated receptor-2, a G protein-coupled receptor activated by serine proteases such as trypsin, tryptase and coagulation factors VIIa and Xa, modulates pancreatic and salivary exocrineExpand
  • Nanae Nagata, Yukiko Kusakari, Yoshifumi Fukunishi, Tsuyoshi Inoue, Yoshihiro Urade
  • Chemistry, Medicine
  • The FEBS journal
  • 2011 (First Publication: 1 April 2011)
  • Aldo-keto reductase 1B1 and 1B3 (AKR1B1 and AKR1B3) are the primary human and mouse prostaglandin F(2α) (PGF(2α)) synthases, respectively, which catalyze the NADPH-dependent reduction of PGH(2), aExpand
  • Tadao Asami, Masaharu Mizutani, +9 authors Shuku Yoshida
  • Chemistry, Medicine
  • The Journal of Biological Chemistry
  • 2001 (First Publication: 13 July 2001)
  • Brassinazole, a synthetic chemical developed in our laboratory, is a triazole-type brassinosteroid biosynthesis inhibitor that induces dwarfism in various plant species. The target sites ofExpand
  • Nanae Nagata, Saori Kosono, Masami Sekine, Atsuhiko Shinmyō, Kunihiko Syōno
  • Biology, Medicine
  • Plant & cell physiology
  • 1995 (First Publication: 1 September 1995)
  • To compare patterns of expression between the Ngrol genes of N. glauca and the Rirol genes of Agrobacterium rhizogenes, we performed fluorometric and histochemical analysis of transgenic geneticExpand
  • Daisuke Irikura, Kosuke Aritake, Nanae Nagata, Toshihiko Maruyama, Shigeru Shimamoto, Yoshihiro Urade
  • Medicine, Biology
  • Journal of Biological Chemistry
  • 2009 (First Publication: 20 March 2009)
  • We report here that 4-dibenzo[a,d]cyclohepten-5-ylidene-1-[4-(2H-tetrazol-5-yl)-butyl]-piperidine (AT-56) is an orally active and selective inhibitor of lipocalin-type prostaglandin (PG) D synthaseExpand